Inogen (INGN) Interest Expenses (2013 - 2022)

Inogen (INGN) reported Interest Expenses of $12000.0 for Q3 2022, down 97.42% year-over-year from $466000.0 in Q3 2021, and down 97.42% quarter-over-quarter from $466000.0 in Q3 2021.

Inogen (INGN) Interest Expenses (2013 - 2022) Analysis & Trends

Inogen (INGN) has 6 years of Interest Expenses data on file, last reported at $12000.0 in Q3 2022.

  • Interest Expenses for Q3 2022 came in at $12000.0, down 97.42% year-over-year; the trailing twelve-month figure through Jun 2023 was $12000.0 (down 97.42% YoY), and the FY2016 annual result was $6000.0, down 72.73% from the prior year.
  • Interest Expenses eased to $12000.0 in Q3 2022 per INGN's latest filing, from $466000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $466000.0 in Q3 2021 and troughed at $12000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 174.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 148.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 96.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.10 Mn
10 Inogen 176.23 Mn 81.82 Mn 37.86 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 12,000.00
Sep 30, 2022 12,000.00
Sep 30, 2021 466,000.00
Sep 30, 2021 466,000.00
Sep 30, 2016 1,000.00
Sep 30, 2016 1,000.00
Jun 30, 2016 2,000.00
Jun 30, 2016 2,000.00
Mar 31, 2016 3,000.00
Mar 31, 2016 3,000.00
Dec 31, 2015 4,000.00
Dec 31, 2015 4,000.00
Sep 30, 2015 5,000.00
Sep 30, 2015 5,000.00
Jun 30, 2015 6,000.00
Jun 30, 2015 6,000.00
Mar 31, 2015 7,000.00
Mar 31, 2015 7,000.00
Dec 31, 2014 9,000.00
Dec 31, 2014 9,000.00